摘要 |
The invention relates to compounds of formula (I) wherein R is hydrogen, low er alkyl, lower alkoxy, halogen or trifluoromethyl; R1 is hydrogen or halogen; or R and R1 may be together -CH=CH-CH=CH-; R2 is hydrogen, halogen, trifluoromethyl, lower alkoxy or cyano; R3 is hydrogen, lower alkyl or form a cycloalkyl group; R4 is hydrogen, -N(R5)2, -N(R5)S(O)2-lower alkyl, - N(R5)C(O)R5 or a cyclic tertiary amine of the group (a); R5 is, independentl y from each other, hydrogen, C3-6-cycloalkyl, benzyl or lower alkyl; R6 is hydrogen, hydroxy, lower alkyl, -N(R5)CO-lower alkyl, hydroxy-lower alkyl, cyano, -CHO or a 5- or 6 membered heterocyclic group, optionally bonded via an alkylene group, X is -C(O)N(R5)-, -(CH2)mO-, -(CH2)mN(R5)-, -N(R5)C(O)-, or - N(R5)(CH2)m-; n is 0-4; and m is 1 or 2; and to pharmaceutically acceptable acid addition salts thereof. It has been shown that the above mentioned compounds have a good affinity to the NK-1 receptor.
|
申请人 |
F. HOFFMANN-LA ROCHE AG |
发明人 |
STADLER, HEINZ;GALLEY, GUIDO;SCHNIDER, PATRICK;HOFFMANN, TORSTEN;HUNKELER, WALTER;GODEL, THIERRY;BOES, MICHAEL |